• Investors
  • Newsroom
  • Working at AMAG
  • Contact
  • About Us
  • Our Commitment
  • Our Products
  • Research & Development
  • Investors
  • Newsroom
  • Working at AMAG
  • Contact
  • Search
Makena® (hydroxyprogesterone caproate injection) Approval and Product Label Remain Unchanged (read more)

Media Contact

Thank you for your interest in learning more about AMAG. Contact Us

Newsroom

  • All News
  • AMAG News
  • Investor News
  • Press Releases
© 2019 AMAG Pharmaceuticals All Rights Reserved Terms of Use | Privacy Policy
  • About Us
  • Our Commitment
  • Our Products
  • Research & Development
  • Investors
  • Newsroom
  • Working at AMAG
  • Contact